OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial

Female doctor holding a pill, medical treatment, drugs and healthcare concept

OxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid to delay a landmark trial set for May in a multibillion-dollar lawsuit by Oklahoma’s attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.